Swiss Bridge Award in Cancer Research Opens for 2024

The Swiss Bridge Foundation, established in 1997, is a private charitable foundation that seeks support for worldwide cancer research from financially independent individuals and corporations. The Foundation looks to support high quality cancer research in Europe.

Funding is available for young investigators at academic and cancer research institutions in Europe to enable them to undertake cancer research focusing on early phase clinical trials. The maximum duration of projects is 36 months.

Two awards are usually awarded annually: one to a researcher in Switzerland, one from elsewhere in Europe.

The total available funding is CHF 500,000, which is split approximately in half for domestic and non-domestic winners. Funds for non-Swiss residents will be paid in US dollars.

Notes of intent are invited from early stage researchers under the age of 45 who hold a PhD or MD and have obtained an independent position at a hospital, university, or research institute in Europe.

(This Bulletin article was the subject of a ResearchConnect news alert.)